Prevention of stone disease

被引:18
|
作者
Porena, M. [1 ]
Guiggi, R. [1 ]
Micheli, C. [1 ]
机构
[1] Monteluce Policlin, Clin Urol Androl, I-06122 Perugia, Italy
关键词
stone disease; prevention; fluid intake; diet; pharmacological therapy;
D O I
10.1159/000104440
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
In recent years stone disease has become more widespread in developed countries. At present the prevalence is 5.2 and 15% of men and 6% of women are affected. The increase is linked to changes in lifestyle, eating patterns and obesity which has become very common. The 'metabolic syndrome' includes all the diseases, e.g. hypertension, lipid imbalances, type 2 diabetes mellitus, gout and cardiovascular disease, which are concomitant in the majority of stone formers. Dietary patterns, besides leading to stone formation, also determine stone chemistry. With a diet that is rich in oxalates, calcium oxalate will constitute 75% of stones, struvite 10-20%, uric acid 5-6% and cystine 1%. As approximately 50% of patients with stones suffer recurrences, metabolic and/or pharmacological prophylaxis is recommended. Copyright (c) 2007 S. Karger AG, Basel.
引用
收藏
页码:37 / 46
页数:10
相关论文
共 50 条
  • [1] PREVENTION OF RENAL STONE DISEASE
    WILLIAMS, HE
    [J]. CLINICAL AND EXPERIMENTAL DIALYSIS AND APHERESIS, 1981, 5 (1-2): : 163 - 172
  • [2] Prevention of recurrent urinary stone disease
    Goka, Selasie Q.
    Copelovitch, Lawrence
    [J]. CURRENT OPINION IN PEDIATRICS, 2020, 32 (02) : 295 - 299
  • [3] Medical prevention of renal stone disease
    Pak, CYC
    [J]. NEPHRON, 1999, 81 : 60 - 65
  • [4] Recurrence prevention of kidney stone disease
    Straub, M.
    [J]. UROLOGE, 2011, 50 (10): : 1323 - 1332
  • [5] Prevention of recurrent stone disease in patients with hyperoxaluria
    Hennessey, D.
    Woolsey, S.
    Duggan, B.
    [J]. BJU INTERNATIONAL, 2016, 117 : 65 - 65
  • [6] Medical Treatment and Prevention of Urinary Stone Disease
    Spradling, Kyle
    Ganesan, Calyani
    Conti, Simon
    [J]. UROLOGIC CLINICS OF NORTH AMERICA, 2022, 49 (02) : 335 - 344
  • [7] Metaphylaxe von HarnsteinerkrankungenRecurrence prevention of kidney stone disease
    M. Straub
    [J]. Der Urologe, 2011, 50 : 1323 - 1334
  • [8] Antibiotic use and the prevention and management of infectious complications in stone disease
    Wollin, Daniel A.
    Joyce, Adrian D.
    Gupta, Mantu
    Wong, Michael Y. C.
    Laguna, Pilar
    Gravas, Stavros
    Gutierrez, Jorge
    Cormio, Luigi
    Wang, Kunjie
    Preminger, Glenn M.
    [J]. WORLD JOURNAL OF UROLOGY, 2017, 35 (09) : 1369 - 1379
  • [9] Antibiotic use and the prevention and management of infectious complications in stone disease
    Daniel A. Wollin
    Adrian D. Joyce
    Mantu Gupta
    Michael Y. C. Wong
    Pilar Laguna
    Stavros Gravas
    Jorge Gutierrez
    Luigi Cormio
    Kunjie Wang
    Glenn M. Preminger
    [J]. World Journal of Urology, 2017, 35 : 1369 - 1379
  • [10] What kind of stone prevention for whom? Risk-adjusted metaphylaxis following urinary stone disease
    Straub, M.
    [J]. UROLOGE, 2006, 45 (11): : 1387 - +